Caring for the Patient with Diabetes
Diabetes mellitus is one of the most common chronic conditions you will meet at the bedside, on the med-surg floor, in the ICU, in the clinic, and in the community. It touches nearly every body system, drives a huge share of hospital admissions, and its day-to-day control depends far more on what the patient does at home than on any single dose you give. That is what makes diabetes nursing so distinctly a nursing problem: the medicine is well understood, but the outcomes hinge on monitoring, timing, judgement, and teaching. A nurse who understands insulin, glucose monitoring, and the warning signs of emergencies can prevent comas, amputations, and deaths that no pill alone will stop.
Learning Objectives
- Distinguish type 1 from type 2 diabetes in pathophysiology, presentation, and management.
- Administer insulin safely, including correct type selection, timing, mixing, and injection technique.
- Perform and interpret blood glucose monitoring and recognize target ranges.
- Identify, prevent, and manage hypoglycemia, DKA, and HHS.
- Explain acute and chronic complications and the nursing interventions that reduce them.
- Deliver structured, teach-back-verified patient education for self-management.
Quick Answer
Type 1 diabetes is an absolute lack of insulin (autoimmune beta-cell destruction) and always requires insulin; type 2 is insulin resistance with relative deficiency, managed with lifestyle, oral agents, and sometimes insulin. Nursing care centers on accurate blood glucose monitoring, safe insulin administration (right insulin, right timing, right technique), and vigilant recognition of hypoglycemia (the most immediate danger) and hyperglycemic crises (DKA in type 1, HHS in type 2). Long-term care aims to prevent complications through glycemic control, foot care, blood pressure and lipid management, and eye and kidney screening. The single most powerful nursing intervention is effective patient education, because the patient manages diabetes every day between visits. Always verify orders and follow local protocol for sliding-scale and IV insulin.
Where It Came From
For most of human history, a diagnosis of what we now call type 1 diabetes was a death sentence. Ancient physicians described the "honey urine" and the terrible thirst and wasting; by the early twentieth century the best available treatment was a near-starvation diet that bought children a few extra, miserable months. The disease revealed the need with brutal clarity: something the pancreas made was keeping people alive, and without it the body literally burned itself up.
That something was isolated in 1921 in Toronto. Frederick Banting, a young surgeon, and Charles Best, a medical student, working in the laboratory of J.J.R. Macleod and with the biochemist James Collip, extracted a pancreatic substance they eventually purified enough to give to humans. In January 1922, a dying 14-year-old named Leonard Thompson became the first person treated; his blood glucose fell, his ketones cleared, and he lived. Banting and Macleod received the Nobel Prize in 1923, and the patent was famously sold to the University of Toronto for one dollar so the drug could reach the world. Insulin did not cure diabetes, but it converted a fatal disease into a manageable chronic one, and in doing so it created the entire field of modern diabetes nursing: someone had to teach injection, monitor for lows, and manage the complications of people who now lived for decades. Later milestones, self-monitoring blood glucose meters in the 1970s to 1980s, the HbA1c test, and the landmark trials showing that tight control prevents complications, all built on that first extract.
Type 1 versus Type 2: Two Diseases, Different Care
Understanding which type you are caring for shapes almost every decision.
Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, so the patient makes essentially no insulin. It often presents in childhood or young adulthood with rapid onset of the classic "three Ps", polyuria, polydipsia, and polyphagia, plus weight loss. These patients depend on exogenous insulin for life; withholding insulin, even briefly, can precipitate diabetic ketoacidosis. There is no such thing as "skipping insulin because you are not eating" in type 1, basal insulin is still needed.
Type 2 diabetes is a disease of insulin resistance combined with a relative insulin deficiency that worsens over time. It is strongly linked to obesity, inactivity, age, and genetics, and often develops silently, many patients are diagnosed on routine labs or when a complication appears. Management starts with nutrition, activity, and weight loss, adds oral agents such as metformin, then GLP-1 receptor agonists or SGLT2 inhibitors, and may eventually require insulin as beta-cell function declines.
Diagnostic thresholds are shared: fasting plasma glucose 126 mg/dL or higher, a 2-hour oral glucose tolerance value of 200 mg/dL or higher, HbA1c of 6.5% or higher, or a random glucose of 200 mg/dL or higher with classic symptoms. HbA1c reflects average glucose over roughly the prior 2 to 3 months and is the anchor for long-term control, with a common target under 7% (individualized, higher for the frail or elderly).
Insulin: Types, Timing, and Safe Administration
Insulin is a high-alert medication, errors can be fatal, so it demands double-checks and precision. Insulins are grouped by how fast they act.
| Category | Examples | Onset | Peak | Duration | Key nursing point |
|---|---|---|---|---|---|
| Rapid-acting | lispro, aspart, glulisine | 10 to 30 min | 30 min to 3 h | 3 to 5 h | Give with or just before a meal; food must be available |
| Short-acting | regular | 30 to 60 min | 2 to 4 h | 5 to 8 h | Only insulin given IV; give 30 min before meals |
| Intermediate | NPH | 1 to 2 h | 4 to 12 h | 12 to 18 h | Cloudy; roll to mix; watch for late peak lows |
| Long-acting | glargine, detemir, degludec | 1 to 2 h | minimal/flat | up to 24 h or more | Do NOT mix with other insulins; basal coverage |
Safe practice essentials:
- Right insulin, right patient: insulin names look alike; always verify against the order, and have a second nurse independently double-check the dose per policy.
- Mixing: when NPH and regular are combined in one syringe, draw up the clear (regular) before the cloudy (NPH), "clear before cloudy," to avoid contaminating the fast-acting vial. Never mix long-acting analogs.
- Injection technique: subcutaneous into abdomen, thigh, upper arm, or buttock; rotate sites within a region to prevent lipohypertrophy, which causes erratic absorption. The abdomen absorbs fastest and most predictably.
- Storage: the in-use vial or pen can stay at room temperature for about 28 days; spares go in the refrigerator (do not freeze).
- Timing with meals: rapid-acting insulin without food on the way is a setup for hypoglycemia, always confirm the meal tray or oral intake.
Worked example (dosage math): A patient is ordered rapid-acting insulin using an insulin-to-carbohydrate ratio of 1 unit per 10 g carbohydrate, plus a correction of 1 unit for every 50 mg/dL above 150. The meal has 60 g carbs and the pre-meal glucose is 250 mg/dL. Meal dose = 60 / 10 = 6 units. Correction = (250 - 150) / 50 = 2 units. Total = 8 units. Always draw insulin in an insulin syringe (units), never a tuberculin or standard syringe.
Blood Glucose Monitoring
Monitoring turns diabetes from guesswork into management. Capillary fingerstick testing (SMBG) is done before meals and at bedtime for many inpatients, and more often during illness, insulin titration, or suspected lows. Continuous glucose monitors (CGMs) now give trend data and alarms, teach patients that a "low arrow trending down" warrants action before symptoms appear.
General inpatient targets are commonly 140 to 180 mg/dL for critically ill patients and premeal values under 140 mg/dL with random values under 180 mg/dL for non-critical patients, but ranges are individualized and protocol-driven. Teach patients technique that changes results: wash hands (fruit residue causes false highs), use the side of the fingertip, and calibrate/rotate testing sites. Document trends, not just single numbers, patterns reveal whether a basal or mealtime dose needs adjustment.
Recognizing and Managing Emergencies
Hypoglycemia (glucose under 70 mg/dL) is the most immediate threat and often a consequence of care: too much insulin, a missed meal, or unexpected exertion. Signs are adrenergic (shaky, sweaty, tachycardic, anxious) and neuroglycopenic (confusion, slurred speech, seizures, coma). Use the Rule of 15: give 15 g of fast carbohydrate (4 oz juice, glucose tablets) if the patient can swallow, recheck in 15 minutes, and repeat until glucose is above 70, then give a longer-acting snack. If the patient is unconscious or unable to swallow, give IM/SC glucagon or IV dextrose (D50) per protocol, never force oral intake in someone who cannot protect the airway. Beta-blockers can mask adrenergic warning signs, a critical teaching and assessment point.
Diabetic ketoacidosis (DKA) is the type 1 crisis: absolute insulin lack drives fat breakdown, ketone production, and metabolic acidosis. Look for hyperglycemia (often 250 to 600 mg/dL), Kussmaul (deep, rapid) respirations, fruity/acetone breath, dehydration, abdominal pain, and altered mental status. Treatment priorities are fluids first (IV normal saline for profound dehydration), then IV insulin infusion, and careful potassium management, insulin drives potassium into cells, so serum potassium can plummet dangerously; do not start insulin if potassium is critically low until it is replaced. Monitor glucose, potassium, and pH closely.
Hyperglycemic hyperosmolar state (HHS) is more typical of type 2, often in older adults with an infection or missed medications. Glucose is extremely high (often above 600 mg/dL), there is profound dehydration and altered consciousness, but little or no ketosis or acidosis because residual insulin prevents fat breakdown. Care is aggressive fluid replacement, insulin, and electrolyte correction, with attention to the precipitating cause.
Chronic Complications and Prevention
Years of hyperglycemia damage blood vessels and nerves, producing the complications that define long-term diabetes care. Microvascular damage causes retinopathy (leading cause of adult blindness, needs annual dilated eye exams), nephropathy (screen with urine albumin and monitor kidney function), and neuropathy (numbness, pain, and the loss of protective sensation in the feet). Macrovascular damage accelerates coronary artery disease, stroke, and peripheral arterial disease. Nursing interventions that genuinely change outcomes include glycemic control, blood pressure and lipid management, smoking cessation counseling, and daily foot inspection. Teach the patient to inspect feet every day, wear proper footwear, never go barefoot, and report any wound immediately, because neuropathy plus poor circulation turns a small blister into an amputation.
Real-World Applications
- On the med-surg floor you will constantly hold or adjust insulin around NPO status, procedures, and steroid orders (steroids raise glucose, expect and anticipate higher readings).
- In the ED, distinguishing DKA from HHS at triage changes fluid and insulin priorities immediately.
- In the clinic you reinforce the "sick-day rules": never stop insulin when ill, check glucose and ketones more often, and stay hydrated, illness is a top cause of DKA admissions.
- In community and home health, you assess a patient's feet, glucometer technique, and refrigerator to catch problems no lab value shows.
Common Mistakes
- "The patient isn't eating, so hold all the insulin." Wrong for type 1: basal (long-acting) insulin covers background needs and stopping it can trigger DKA even without food. Correction: clarify orders, typically hold mealtime insulin for NPO but continue basal, and check glucose frequently.
- Treating a low with a chocolate bar or "as much as they want." Fat in chocolate slows sugar absorption, and overtreating causes rebound hyperglycemia. Correction: use exactly 15 g of fast carbohydrate and recheck in 15 minutes.
- Assuming a high reading is real without checking the fingertip. Juice or fruit residue on the finger produces falsely high results, leading to unnecessary insulin. Correction: always have the patient wash and dry hands before SMBG.
- Shaking a cloudy insulin (NPH) vigorously or drawing cloudy before clear. Shaking causes foaming and dosing error; contaminating the regular vial ruins its fast action. Correction: gently roll NPH, and draw clear before cloudy.
Comparison and Connections
| Feature | DKA | HHS |
|---|---|---|
| Typical type | Type 1 | Type 2 |
| Glucose | 250 to 600 mg/dL | often above 600 mg/dL |
| Ketones/acidosis | Marked | Minimal/absent |
| Breathing | Kussmaul, fruity breath | Usually normal |
| Onset | Hours to a day | Days |
| Core danger | Acidosis and potassium shifts | Extreme dehydration, hyperosmolarity |
Both share the priorities of fluids, insulin, and potassium, but DKA is defined by acidosis while HHS is defined by osmolarity. Contrast this with hypoglycemia, the opposite emergency, where the fix is sugar, not insulin. See related pharmacology of insulin and oral agents in Pharmacology for Nurses and the broader med-surg overview in Medical-Surgical Nursing.
Practice Questions
Recall
Which insulin is the only one that can be given intravenously? Answer: Regular (short-acting) insulin. Rapid-acting analogs are sometimes used IV in specialized settings, but classically regular insulin is the IV-compatible choice for infusions.
Understanding
Why must basal insulin usually be continued in a type 1 patient who is NPO, while mealtime insulin is held? Answer: Type 1 patients produce no insulin, so background (basal) insulin is needed continuously to suppress ketone production and prevent DKA, independent of food. Mealtime (bolus) insulin covers carbohydrate intake, so it is held when the patient is not eating to avoid hypoglycemia.
Application
A patient's premeal glucose is 300 mg/dL. Using a correction of 1 unit per 50 mg/dL above 150 and an insulin-to-carb ratio of 1 unit per 15 g for a 45 g meal, calculate the total rapid-acting dose. Answer: Correction = (300 - 150) / 50 = 3 units. Meal = 45 / 15 = 3 units. Total = 6 units. Confirm the meal is available before administering.
Analysis
An older type 2 patient with pneumonia arrives confused, with glucose of 780 mg/dL, dry mucous membranes, normal respirations, and negative serum ketones. What is the priority and why? Answer: This is HHS, not DKA (no ketosis/acidosis, extreme hyperglycemia, precipitating infection). The priority is aggressive IV fluid resuscitation to correct profound dehydration and hyperosmolarity, followed by insulin and electrolyte correction and treating the pneumonia. Fluids precede insulin.
FAQ
Can a type 2 patient ever need insulin? Yes. Type 2 is progressive; as beta-cell function declines, oral agents may no longer suffice, and insulin is added. Needing insulin is not a sign of failure, it reflects the natural course of the disease.
Why does my patient's glucose spike after starting steroids? Glucocorticoids increase insulin resistance and hepatic glucose output. Anticipate higher readings, especially in the afternoon and evening, and expect the team to adjust insulin, then taper it down as steroids are reduced.
What is HbA1c and how is it different from a fingerstick? A fingerstick is a snapshot of glucose right now; HbA1c reflects average glucose over the past 2 to 3 months by measuring glycated hemoglobin. It guides long-term control and is not used to make immediate dosing decisions.
How do I treat a low if the patient is unconscious? Do not give anything by mouth, aspiration risk. Give IM or subcutaneous glucagon, or IV dextrose (D50) if you have access, per protocol, then recheck glucose and provide carbohydrate once alert and able to swallow.
Why is foot care such a big deal in diabetes? Neuropathy dulls sensation and poor circulation slows healing, so a small unnoticed injury can become an ulcer and lead to amputation. Teach daily foot inspection, proper footwear, never going barefoot, and prompt reporting of any wound.
Quick Revision
- Type 1 = no insulin (autoimmune), always needs insulin, risk of DKA. Type 2 = insulin resistance, lifestyle/oral agents first.
- Insulin is high-alert: verify, double-check, use insulin syringes, rotate sites, clear before cloudy, never mix long-acting analogs.
- Only regular insulin goes IV.
- Hypoglycemia (under 70): Rule of 15; glucagon/D50 if unconscious. Most immediate danger.
- DKA: type 1, ketosis + acidosis, Kussmaul/fruity breath. HHS: type 2, extreme glucose, no ketosis, severe dehydration. Both: fluids, insulin, potassium.
- HbA1c under 7% (individualized) is the long-term target; wash hands before SMBG.
- Never stop insulin during illness; teach sick-day rules and daily foot care.
Related Topics
Prerequisites
Related Topics
- Medical-Surgical Nursing overview
- Endocrinology in Medicine